Don't Rely on Pregnancy Letter Categories to Make Treatment Recommendations

August 2015

Pregnancy categories (A, B, C, D, X) will start to DISAPPEAR from Rx drug labels...due to new rules on reporting pregnancy and lactation risks.

It's been a long time coming...over 20 years since FDA's labeling change initiative began. Now it's finally starting to hit drug labels.

More relevant info to help with therapy decisions will replace the A, B, C, D, and X categories...because these "letters" oversimplify and don't consistently explain the degree of fetal risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Antithrombotics "Bridge" Fewer Warfarin Patients With Enoxaparin
STIs Consider Prescribing "Expedited Partner Therapy" for STDs
COPD Think of Stiolto Respimat as Similar to Anoro Ellipta for COPD
Diabetes Don't Convert Doses When Switching From Humalog U-100 to U-200
Kidney Stones Don't Routinely Write for Tamsulosin or Nifedipine to Pass Kidney Stones
Osteoarthritis Keep Acetaminophen in Your Osteoarthritis Toolbox
Photosensitivity Advise Taking Photosensitizing Meds in the Evening
Prediabetes Don't Use Gliptins to Manage Prediabetes
Substance Use Disorder Use a Buprenorphine/Naloxone COMBO for Opioid Dependence
Phosphate Consider Using Auryxia to Bind Phosphate AND Increase Iron
Pregnancy Don't Rely on Pregnancy Letter Categories to Make Treatment Recommendations
Cardiology Don't Let PCSK9 Inhibitors Steer You Away From Statins

Don't Rely on Pregnancy Letter Categories to Make Treatment Recommendations

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents